L2IV34 Stock Overview
A medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
LivaNova PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$29.88 |
| 52 Week High | US$40.62 |
| 52 Week Low | US$29.88 |
| Beta | 1.01 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -23.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| L2IV34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | 0.9% |
| 1Y | n/a | 14.6% | -0.4% |
Return vs Industry: Insufficient data to determine how L2IV34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how L2IV34 performed against the BR Market.
Price Volatility
| L2IV34 volatility | |
|---|---|
| L2IV34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BR Market | 8.1% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: L2IV34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine L2IV34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 2,900 | Vladimir Makatsaria | www.livanova.com |
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
LivaNova PLC Fundamentals Summary
| L2IV34 fundamental statistics | |
|---|---|
| Market cap | R$16.08b |
| Earnings (TTM) | R$135.79m |
| Revenue (TTM) | R$7.12b |
118.4x
P/E Ratio2.3x
P/S RatioIs L2IV34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L2IV34 income statement (TTM) | |
|---|---|
| Revenue | US$1.24b |
| Cost of Revenue | US$396.25m |
| Gross Profit | US$845.49m |
| Other Expenses | US$821.80m |
| Earnings | US$23.68m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 68.09% |
| Net Profit Margin | 1.91% |
| Debt/Equity Ratio | 47.8% |
How did L2IV34 perform over the long term?
See historical performance and comparison